Welcome to the AAO’s Mid Year Forum (MYF) 2018! I look forward to meeting a lot of you very soon. I was part of the inaugural Advocacy Ambassador class in 2004. Fifteen years later, I am still actively involved with advocating for my patients and our profession.
The MYF is where ophthalmology leaders meet. On Wednesday evening, we will have dinner together describing Thursday’s Congressional Advocacy Day activities. You will partner up with your state’s ophthalmology leaders where we will visit your legislator’s office. Be prepared to (typically) meet with the health legislative assistant, who is very knowledgeable about health care issues. In some cases, you will get to meet your legislator and will be given an opportunity to take a photo (remember to remove your name tag). Call Senators, Mr. Senator Henrich (NM) or Madame Lujan-Grisham (NM) or Representative Smith. When entering their office, know who you are meeting with, this will be given to you in advance. For example, Good morning, we are here to see the Congresswoman or the Congressman or Stuart Martinez, we are from the American Academy of Ophthalmology. Carry very little in your pockets because you will have to walk through a metal detector upon entering every building. Bring business cards if you have them.
Our main issues this year for Congressional Advocacy Day (Thursday):
1. The Technology based Eye Care Services (TECS) program is a clinical care initiative funded though the Department of Veterans Affairs Office of Rural Health (ORH).
The Future of Artificial Intelligence in Ophthalmology
12:15 p.m. – 2 p.m.
Moderator: Rahul Khurana, MD – Editor in Chief, The ONE Network, American Academy of Ophthalmology
The next transformation in ophthalmology is the application of artificial intelligence in diagnosing and treating disease in clinical practice. It is beginning to be used in retinal disease for detecting diabetic retinopathy and diabetic macular edema from fundus photographs, and its potential is to provide more efficient and objective analysis of images and prediction of disease progression. The session will explore what artificial intelligence means for practicing ophthalmologists, its promise and limitations, and what the future holds.